Brent Pfeiffenberger Century Therapeutics, Inc. (IPSC) insider trading activity

Brent Pfeiffenberger is President and CEO of Century Therapeutics, Inc.. Currently has a direct ownership of 1.68 Million shares of IPSC, which is worth approximately $942,064. The most recent transaction as insider was on May 16, 2025, when has been sold 29,552 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $16,253. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.68M

41.06% 3M change

14.38% 12M change

Total Value Held $942,064

Brent Pfeiffenberger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2025	SELL Open market or private sale	$16,253 $0.55 p/Share	29,552 Reduced 1.73%	1,682,258 Common Stock
Mar 11 2025	BUY Grant, award, or other acquisition	-	521,500 Added 23.35%	1,711,810 Common Stock
Mar 10 2025	SELL Open market or private sale	$1,385 $0.62 p/Share	2,235 Reduced 0.19%	1,190,310 Common Stock
Feb 18 2025	SELL Open market or private sale	$27,075 $0.78 p/Share	34,712 Reduced 2.83%	1,192,545 Common Stock
Dec 04 2024	SELL Payment of exercise price or tax liability	$350,563 $1.44 p/Share	243,447 Reduced 16.55%	1,227,257 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	17,425 Added 1.17%	1,470,704 Common Stock
Dec 04 2023	BUY Grant, award, or other acquisition	-	1,453,279 Added 50.0%	1,453,279 Common Stock

Also insider at

BFLY

Butterfly Network, Inc. Healthcare

President and CEO